Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3.

Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3.

We have investigated the effects of short-term neoadjuvant and long-term androgen deprivation therapies (ADTs) on β-microseminoprotein (MSMB) and cysteine-rich secretory protein-3 (CRISP3) expression in prostate cancer patients. We also studied if MSMB expression was related to genotype and epigenet...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Dahlman, A, Edsjö, A, Halldén, C, Persson, J, Fine, S, Lilja, H, Gerald, W, Bjartell, A
Natura:	Journal article
Lingua:	English
Pubblicazione:	2010

Documenti analoghi

A novel MSMB-related microprotein in the postovulatory egg coats of marsupials
di: Frankenberg Stephen, et al.
Pubblicazione: (2011-12-01)

Rapidly evolving marmoset MSMB genes are differently expressed in the male genital tract
di: Ceder Yvonne, et al.
Pubblicazione: (2009-09-01)

Alterations in <it>LMTK2</it>, <it>MSMB </it>and <it>HNF1B </it>gene expression are associated with the development of prostate cancer
di: McCullagh Paul, et al.
Pubblicazione: (2010-06-01)

Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis.
di: Mark M Pomerantz, et al.
Pubblicazione: (2010-11-01)

A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations.
di: Waters, K, et al.
Pubblicazione: (2010)

Improved production of cytotoxic thailanstatins A and D through metabolic engineering of Burkholderia thailandensis MSMB43 and pilot scale fermentation
di: Xiangyang Liu, et al.
Pubblicazione: (2016-03-01)

A Multi-Omics-Based Exploration of the Predictive Role of MSMB in Prostate Cancer Recurrence: A Study Using Bayesian Inverse Convolution and 10 Machine Learning Combinations
di: Shan Huang, et al.
Pubblicazione: (2025-02-01)

β-Microseminoprotein binds CRISP-3 in human seminal plasma
di: Udby, L, et al.
Pubblicazione: (2005)

beta-Microseminoprotein binds CRISP-3 in human seminal plasma.
di: Udby, L, et al.
Pubblicazione: (2005)

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
di: Shtutman Michael, et al.
Pubblicazione: (2010-04-01)

The early effects of rapid androgen deprivation on human prostate cancer
di: Shaw, G, et al.
Pubblicazione: (2015)

Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells.
di: Dominick G A Burton, et al.
Pubblicazione: (2013-01-01)

Impact of Androgen Deprivation on Oxidative Stress and Antioxidant Status in Nigerian Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy
di: Iya Eze Bassey, et al.
Pubblicazione: (2020-11-01)

Metabolomic effects of androgen deprivation therapy treatment for prostate cancer
di: Jen‐Tsan Chi, et al.
Pubblicazione: (2020-06-01)

CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer
di: Justin H. Hwang, et al.
Pubblicazione: (2019-11-01)

miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
di: Hagman, Z, et al.
Pubblicazione: (2010)

An Update on the Changing Indications for Androgen Deprivation Therapy for Prostate Cancer
di: Kristene Myklak, et al.
Pubblicazione: (2011-01-01)

Metabolic changes in patients with prostate cancer with androgen deprivation therapy
di: Maxim N. Peshkov, et al.
Pubblicazione: (2020-06-01)

Impact of Androgen Deprivation Therapy on Cardiovascular Outcomes in Prostate Cancer
di: Laurence Klotz, et al.
Pubblicazione: (2022-07-01)

Immunosuppressive environment in response to androgen deprivation treatment in prostate cancer
di: Caipeng Qin, et al.
Pubblicazione: (2022-11-01)

Relugolix – The novel oral androgen deprivation therapy for prostate cancer
di: Rahul Jena
Pubblicazione: (2020-01-01)

Transcription factors involved in prostate gland adaptation to androgen deprivation.
di: Rafaela Rosa-Ribeiro, et al.
Pubblicazione: (2014-01-01)

Androgen deprivation therapy for prostate cancer and the risk of hematologic disorders.
di: Jui-Ming Liu, et al.
Pubblicazione: (2020-01-01)

Antifracture agents for prostate cancer patients on androgen deprivation therapy
di: Bhupendra P Singh, et al.
Pubblicazione: (2010-01-01)

COMBINED RADIATION THERAPY FOR PROSTATE CANCER WITH DOSE ESCALATION BRACHYTHERAPY AND ANDROGEN DEPRIVATION
di: Auchynikau V. A., et al.
Pubblicazione: (2018-09-01)

The castration level of testosterone and hormonal resistance of prostate cancer in androgen deprivation therapy
di: I. G. Rusakov, et al.
Pubblicazione: (2020-12-01)

Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer
di: Ritika Tiwari, et al.
Pubblicazione: (2020-01-01)

Neutrosophic Crisp Points & Neutrosophic Crisp Ideals
di: A. A. Salama
Pubblicazione: (2013-03-01)

Reduced NCOR2 expression accelerates androgen deprivation therapy failure in prostate cancer
di: Mark D. Long, et al.
Pubblicazione: (2021-12-01)

Cystatin C is downregulated in prostate cancer and modulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pathways.
di: Barbara Wegiel, et al.
Pubblicazione: (2009-11-01)

Prostate-specific antigen dynamics predict individual responses to intermittent androgen deprivation
di: Renee Brady-Nicholls, et al.
Pubblicazione: (2020-04-01)

Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer.
di: Klein, R, et al.
Pubblicazione: (2010)

External radiotherapy for prostate cancer with or without androgen deprivation: Geneva, 1991 to 2004
di: R Miralbell, et al.
Pubblicazione: (2009-09-01)

Adaptive and non-adaptive gene expression responses in prostate cancer during androgen deprivation
di: Reetta Nätkin, et al.
Pubblicazione: (2023-01-01)

Adaptive and non-adaptive gene expression responses in prostate cancer during androgen deprivation.
di: Reetta Nätkin, et al.
Pubblicazione: (2023-01-01)

Sequence of androgen receptor-targeted vaccination with androgen deprivation therapy affects anti-prostate tumor efficacy
di: Douglas G McNeel, et al.
Pubblicazione: (2024-05-01)

Effects of the intestinal microbiota on prostate cancer treatment by androgen deprivation therapy
di: Safae Terrisse, et al.
Pubblicazione: (2022-11-01)

The Effect of Androgen Deprivation Therapy on the Cardiovascular System in Advanced Prostate Cancer
di: Allison B. Reiss, et al.
Pubblicazione: (2024-10-01)

Androgen deprivation therapy and fracture risk in Chinese patients with prostate carcinoma.
di: Chi-Ho Lee, et al.
Pubblicazione: (2017-01-01)

Androgen Deprivation Therapy for Prostate Cancer: Focus on Cognitive Function and Mood
di: Allison B. Reiss, et al.
Pubblicazione: (2023-12-01)